CG Oncology, Inc. Common stockCGONNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-4.90%
↑ 69% above average
Average (11q)
-15.74%
Historical baseline
Range
High:0.00%
Low:-34.81%
Volatility
-221.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -4.90% |
| Q2 2025 | -15.49% |
| Q1 2025 | -10.92% |
| Q4 2024 | -34.47% |
| Q3 2024 | -9.45% |
| Q2 2024 | -15.06% |
| Q1 2024 | -18.68% |
| Q4 2023 | -34.81% |
| Q3 2023 | -13.93% |
| Q2 2023 | -26.80% |
| Q1 2023 | -4.36% |
| Q4 2022 | 0.00% |